prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. SENTINEL NODES RIGHT AXILLA. B. RIGHT BREAST NEEDLE LOCALIZATION. SPECIMEN(S): A. SENTINEL NODES RIGHT AXILLA. B. RIGHT BREAST NEEDLE LOCALIZATION. GROSS DESCRIPTION: A. SENTINEL NODES RIGHT AXILLA. Received fresh are four tan pink lymph nodes ranging from 0.4cm to 2cm. Four touch preps are taken. A1: 1 lymph node. A2: 1 lymph node. A3: 1 lymph node. A4: 1 lymph node. B. RIGHT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and "WLE right breast needle localization" is a previously. inked oriented 204g, 12.5 x 10 x 7.5cm needle localized lumpectomy with radiograph. Ink code: anterior-yellow,. posterior-black, superior-blue, inferior-orange, medial-green, lateral-red. Specimen is serially sectioned from lateral. to medial into 11 slices revealing 4 masses: Mass #1- 0.4cm, 1.3cm from the anterior margin in slice 5. Mass #2- 0.3cm, 1.5cm from mass #1 and 2.5cm from anterior margin in slice 5. Mass #3- 3.5 x 2.6 x 2cm, 0.5cm from the anterior and posterior margins in slice 6-9. Mass #4- 1cm, 2cm from mass #3 and 2cm from the deep margin in slice 6. A portion of the specimen is submitted for tissue procurement. Representatively submitted: B1: lateral margin slice 1. B2: slice 2. B3: biopsy site slice 2. B4: slice 2. B5-B9: slice 4. B10: mass #1 with anterior margin slice 5. B11: superior margin slice 5. B12: area in between mass #1 and mass #2 slice 5. B13: slice 5. B14: slice 5. B15: inferior margin slice 5. B16: deep margin slice 5. B17-B19: mass #3 slice 6. B20: mass #4 slice 6. B21: deep margin slice 6. B22-B25: mass #3 slice 7. B26-B27: mass #3 slice 8. B28-B30: mass #3 with clip ID in B28 slice 9. B31-B32: slice 10. B33-B34: medial margin slice 11. DIAGNOSIS: A. SENTINEL LYMPH NODES, RIGHT AXILLA, BIOPSY: - ONE OF FOUR LYMPH NODES WITH ISOLATED TUMOR CELLS (0/4). NOTE: Cytokeratin AE1/3 stains were performed on A1 and A4 and is negative in A1 and positive in A4, highlighting. scattered tumor cells. On the cytokeratin AE1/3 stain, - 100 cytokeratin positive cells are seen, a feature that would. be consistent with isolated tumor cells versus a micrometastasis. The touch prep of A4 was reviewed and tumor cells. were not seen. B. BREAST, RIGHT NEEDLE LOCALIZATION WIDE LOCAL EXCISION: - INVASIVE LOBULAR CARCINOMA, SBR GRADE 2. TUMOR MEASURES AT LEAST 3.5 CM. - TUMOR IS PRESENT AT THE ANTERIOR MARGIN. - LOBULAR CARCINOMA IN SITU (LCIS) AND COLUMNAR CELL CHANGE. - ONE INTRAMAMMARY LYMPH NODE, NO TUMOR SEEN (0/1). - SKELETAL MUSCLE, NO TUMOR SEEN. NOTE: Grossly, several lesions were noted that microscopically correspond to invasive carcinoma. The size of the. tumor is difficult to determine. While the single largest focus of tumor grossly is 3.5 cm, microscopically, invasive. carcinoma is present in 6 of 11 slices of a 12.5 cm specimen and therefore may span - 6 cm. Clinical-radiologic. correlation is recommended. A 0.5cm intramammary lymph node was also identified. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization;. Laterality: Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 3.5cm. Tumor Site: 8:00. Margins: Involved at. anterior. Extent:: 0.1 cm. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Sentinel lymph node. Non-sentinel lymph node. Lymph node status: Negative 0/5 Isolated tumor cell clusters. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT2N0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: Medial ? additional flap of tissue. PRE-OPERATIVE DIAGNOSIS: Right breast carcinoma. INTRAOPERATIVF CONSI II TATION. , Right axilla: No tumor cells seen on four touch preps. Diagnosis called to Dr. Dr. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 29. CLINICAL EXPERIENCE: Patients with a recurrence score of: 29 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 19%. ER Score: 11 Positive. PR Score: 7.1 Positive. Her2 Score: 8 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Final Review: Pathologist. Final: Pathologist. Addendum: Pathologist,. Addendum Final: Pathologist,.

expanded version (tokens=1835) : 
 Histological classification:
- Invasive lobular carcinoma, SBR grade 2
- Lobular carcinoma in situ (LCIS) and columnar cell change

Subtype: Luminal A

Description of any necrosis: Absent

Tumor infiltrating lymphocytes: None identified

Histological grade: Modified Scarff Bloom Richardson Grade 2

Nuclear grade: 2

Lymphovascular invasion: None identified 

Calcification: Not mentioned

Receptor Status:
ER: Positive
PR: Positive
HER2: Negative by IHC

Ancillary testing results:
- Cytokeratin AE1/3 stains were performed and highlighted scattered tumor cells.
- Oncotype DX breast cancer assay recurrence score: 29. 
- Recurrence rate at 10 years for patients with a recurrence score of 29 is 19%.

Other points to note:
- The tumor measures at least 3.5 cm, but may span up to 6 cm as invasive carcinoma is present in 6 of 11 slices of the specimen.
- One of the four lymph nodes in the right axilla had isolated tumor cells (0/4).
- The gross size of the tumor is difficult to determine due to the presence of multiple lesions. 
- Clinical-radiologic correlation is recommended. 

Overall, the report describes the presence of invasive lobular carcinoma, positive ER/PR receptor status and negative HER2 receptor status. The tumor measures at least 3.5 cm

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1982) : 
 The breast pathology report indicates the presence of LumA subtype invasive lobular carcinoma, SBR grade 2, with no necrosis or tumor infiltrating lymphocytes. One of four axillary lymph nodes has isolated tumor cells. ER/PR is positive and HER2 is negative. The gross size of the tumor is not entirely conclusive. A recurrence score of 29 in the Oncotype DX test suggests a 19% recurrence rate over 10 years. Clinical-radiologic correlation is advised.

